CMV disease resistant to Ganciclovir. Should valganciclovir plasma levels be monitored in high risk patients?
Enfermedad por CMV resistente a ganciclovir ¿Está indicado monitorizar niveles plasmáticos de valganciclovir en pacientes de alto riesgo ?
Read
7170
Timeswas read the article
1895
Total PDF
5275
Total HTML
Share statistics
array:21 [ "pii" => "X201325140900507X" "issn" => "20132514" "doi" => "10.3265/NEFROLOGIA.2009.29.2.4889.EN.FULL" "estado" => "S300" "fechaPublicacion" => "2009-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:180-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3243 "formatos" => array:3 [ "EPUB" => 238 "HTML" => 2563 "PDF" => 442 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699509005072" "issn" => "02116995" "doi" => "10.3265/NEFROLOGIA.2009.29.2.4889.EN.FULL" "estado" => "S300" "fechaPublicacion" => "2009-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2009;29:180-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7476 "formatos" => array:3 [ "EPUB" => 241 "HTML" => 6718 "PDF" => 517 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Enfermedad por CMV resistente a ganciclovir ¿Está indicado monitorizar niveles plasmáticos de valganciclovir en pacientes de alto riesgo ?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "180" "paginaFinal" => "181" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "CMV disease resistant to Ganciclovir. Should valganciclovir plasma levels be monitored in high risk patients?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "EUGENIA SOLA, ENCARNACION VEGA, CRISTINA GUTIERREZ, VERONICA LOPEZ, MERCEDES CABELLO, DOLORES BURGOS, MIGUEL GONZALEZ MOLINA, JUAN SILES" "autores" => array:8 [ 0 => array:2 [ "nombre" => "EUGENIA" "apellidos" => "SOLA" ] 1 => array:2 [ "nombre" => "ENCARNACION" "apellidos" => "VEGA" ] 2 => array:2 [ "nombre" => "CRISTINA" "apellidos" => "GUTIERREZ" ] 3 => array:2 [ "nombre" => "VERONICA" "apellidos" => "LOPEZ" ] 4 => array:2 [ "nombre" => "MERCEDES" "apellidos" => "CABELLO" ] 5 => array:2 [ "nombre" => "DOLORES" "apellidos" => "BURGOS" ] 6 => array:2 [ "nombre" => "MIGUEL" "apellidos" => "GONZALEZ MOLINA" ] 7 => array:2 [ "nombre" => "JUAN" "apellidos" => "SILES" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X201325140900507X" "doi" => "10.3265/NEFROLOGIA.2009.29.2.4889.EN.FULL" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325140900507X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005072?idApp=UINPBA000064" "url" => "/02116995/0000002900000002/v0_201502091411/X0211699509005072/v0_201502091411/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251409005061" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.2.4911.en.full" "estado" => "S300" "fechaPublicacion" => "2009-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:181" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3494 "formatos" => array:3 [ "EPUB" => 216 "HTML" => 2826 "PDF" => 452 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Cefepime-induced encephalopathy in patients with renal failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "181" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "ENCEFALOPATÍA POR CEFEPIMA EN PACIENTES CON INSUFICIENCIA RENAL." ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carmen Martín Herrera, Macarena Navarro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Carmen" "apellidos" => "Martín Herrera" ] 1 => array:2 [ "nombre" => "Macarena" "apellidos" => "Navarro" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509005064" "doi" => "10.3265/Nefrologia.2009.29.2.4911.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005064?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005061?idApp=UINPBA000064" "url" => "/20132514/0000002900000002/v0_201502091631/X2013251409005061/v0_201502091631/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251409004967" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.2.5057.en.full" "estado" => "S300" "fechaPublicacion" => "2009-04-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:178-80" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3439 "formatos" => array:3 [ "EPUB" => 241 "HTML" => 2749 "PDF" => 449 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "The current situation for vascular access in the province of Caceres" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "178" "paginaFinal" => "180" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "SITUACIÓN ACTUAL DEL ACCESO VASCULAR EN LA PROVINCIA DE CÁCERES" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "21518078_t1_p178.jpg" "Alto" => 178 "Ancho" => 543 "Tamanyo" => 27346 ] ] "descripcion" => array:1 [ "en" => "Types of vascular access in incident and prevalent patients" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "INÉS CASTELLANO CERVIÑO, SANDRA GALLEGO DOMÍNGUEZ, MIGUEL ÁNGEL SUÁREZ SANTISTEBAN, PETRA MARÍA GONZÁLEZ CASTILLO, NOURA GAD" "autores" => array:5 [ 0 => array:2 [ "nombre" => "INÉS" "apellidos" => "CASTELLANO CERVIÑO" ] 1 => array:2 [ "nombre" => "SANDRA" "apellidos" => "GALLEGO DOMÍNGUEZ" ] 2 => array:2 [ "nombre" => "MIGUEL ÁNGEL" "apellidos" => "SUÁREZ SANTISTEBAN" ] 3 => array:2 [ "nombre" => "PETRA MARÍA" "apellidos" => "GONZÁLEZ CASTILLO" ] 4 => array:2 [ "nombre" => "NOURA" "apellidos" => "GAD" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X021169950900496X" "doi" => "10.3265/Nefrologia.2009.29.2.5057.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950900496X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004967?idApp=UINPBA000064" "url" => "/20132514/0000002900000002/v0_201502091631/X2013251409004967/v0_201502091631/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "CMV disease resistant to Ganciclovir. Should valganciclovir plasma levels be monitored in high risk patients?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "180" "paginaFinal" => "181" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "EUGENIA SOLA, ENCARNACION VEGA, CRISTINA GUTIERREZ, VERONICA LOPEZ, MERCEDES CABELLO, DOLORES BURGOS, MIGUEL GONZALEZ MOLINA, JUAN SILES" "autores" => array:8 [ 0 => array:4 [ "nombre" => "EUGENIA" "apellidos" => "SOLA" "email" => array:1 [ 0 => "esola_@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "ENCARNACION" "apellidos" => "VEGA" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "nombre" => "CRISTINA" "apellidos" => "GUTIERREZ" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "nombre" => "VERONICA" "apellidos" => "LOPEZ" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "MERCEDES" "apellidos" => "CABELLO" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "nombre" => "DOLORES" "apellidos" => "BURGOS" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 6 => array:3 [ "nombre" => "MIGUEL" "apellidos" => "GONZALEZ MOLINA" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 7 => array:3 [ "nombre" => "JUAN" "apellidos" => "SILES" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "SERVICIO DE NEFROLOGIA, HOSPITAL CARLOS HAYA, MALAGA, MALAGA, ESPAÑA, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad por CMV resistente a ganciclovir ¿Está indicado monitorizar niveles plasmáticos de valganciclovir en pacientes de alto riesgo ?" ] ] "textoCompleto" => "<p class="elsevierStylePara">Dear Editor,</p><p class="elsevierStylePara">We report the case of a patient who received a kidney transplant in June 2007. The donor was Ig G CMV positive and the recipient was negative. The immunosuppression consisted of steroids, mycophenolate (1g/day) and tacrolimus (0.1mg/12 h). Borderline/acute rejection occurred on the 11th day post-transplant and was successfully treated with steroids.</p><p class="elsevierStylePara">The patient was discharged with good renal function, Cr 0.9mg/dl on prophylactic treatment with valganciclovir, for six months having to repeatedly adjust the doses because of leucopenia. CMV viral load was negative whilst on treatment.</p><p class="elsevierStylePara">10 days after discontinuing treatment, the patient presented with diarrhoea, abdominal pain, fever, leucopenia and thrombocytopenia, and deterioration of renal function, blood and urine cultures were negative and CMV- PCR was positive, 101,000 copies/ml.</p><p class="elsevierStylePara">Treatment was started with valganciclovir and the dose of MMF was reduced. The fever subsided and the CMV viral load began to decrease.</p><p class="elsevierStylePara">The patient was discharged with stable kidney function (1mg/dl), without leucopenia and on treatment with valganciclovir.</p><p class="elsevierStylePara">A few days later, the patient presented with low fever, abdominal pain and persistent CMV viral load (4,900cop/ml). The patient received treatment with intravenous ganciclovir during 20 days until the CMV viral load was negative in blood. The patient was discharged without symptoms, with normal leucocyte count and on valganciclovir treatment.</p><p class="elsevierStylePara">Three days after discharge, the patient developed fever, epigastrium pain and leucopenia again. CMV- PCR was negative in blood. Screening for acute febrile illness was negative except for discreet hepatosplenomegaly. The upper endoscopy showed normal mucosa of which biopsies were taken. The qualitative PCR of the gastric tissue was positive for CMVand HSV 6. Intravenous gancyclovir was reinitiated. Non-specific abdominal pain persisted along with anaemia and leucopenia, needing treatment with granulocyte colony-stimulating factor, transfusion of erythrocyte concentrate. The patient continued to have low-grade fever. The CMV serum PCR remained negative.</p><p class="elsevierStylePara">Suspecting CMV disease resistant to ganciclovir, a drug resistance test was carried out on the gastric specimen. An L 595F mutation in UL97 was found.</p><p class="elsevierStylePara">The UL97 gene regulates the phosphorylation of the ganciclovir associated with resistance to it. We then began treatment with intravenous foscarnet and specific anti-CMV immunoglobulin 200mg/kg every three weeks. The patient became asymptomatic after 10 days of treatment with normal leukocyte count. The complications of this treatment included transient acute kidney failure at two weeks, with hypomagnesaemia and hypokalaemia.</p><p class="elsevierStylePara">The treatment continued for one month, followed by valganciclovir and foscarnet every 48 hours until the therapeutic levels of valganclovir were confirmed. Since then, the patient has remained asymptomatic and with excellent kidney function, six months after the episode.</p><p class="elsevierStylePara">The difficulty in diagnosing CMV Diease in this case was because of the false negative CMV viral load test requiring the confirmation of CMV and its resistance on gastric tissue. The resistance of the treatment was probably enhanced by inadequate doses of valganciclovir, which stresses the importance of monitoring vanganciclovir levels to ensure an adequate treatment thus avoiding the development of resistance to the treatment.</p>" "pdfFichero" => "P-E-S-A216-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "1.- Eid AJ, Arthus SK, Deziel PJ, Wilhelm MP, Razonable RR.Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes.Clin Transplant. 2008;22(2):162-70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18339135" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "2.- Nogueira E, Ozaki Ks; Vomitaba H, Granato CF, Camara MO, Pacheco-Silva A. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.Int Immunopharmacol. 2006 ,20(6):2031-7" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S073510971101549X" "estado" => "S300" "issn" => "07351097" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "3.-Boivin G, Goyette N, Gilbert E, Covington E. Analysis of Cytomegalovirus DNA Polymerase (UL54) Mutations in Solid Organ Transplant Patients Receiving Valganciclovir Ganciclovir Prophylaxis. J Med Virol 2005; 77: 425-429. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16173018" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S0168822712004913" "estado" => "S300" "issn" => "01688227" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "4.- Cervera C. Pineda M, Linares L, marcos MA, Antón A, Cofán F, Ricart MJ, Navasa M, Pérez-Villa F, Fumarola T, Moreno A. Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.Transplant Proc. 2007 Sep;39(7):2228-30 <a href="http://www.ncbi.nlm.nih.gov/pubmed/17889146" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "5.- A. Asberga, , A. Humar , H. Rollagc, A. G. Jardined, H. Mouase, M. D. Pescovitz;D. Sgarabottog, M. Tuncerh, I. L. Noronhai and A. Hartmannj, on behalf of the VICTOR Study Group. Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients American Journal of Transplantation 2007; 7: 2106¿2113" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002900000002/v0_201502091631/X201325140900507X/v0_201502091631/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000002/v0_201502091631/X201325140900507X/v0_201502091631/en/P-E-S-A216-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325140900507X?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 8 | 5 | 13 |
| 2024 October | 40 | 31 | 71 |
| 2024 September | 54 | 28 | 82 |
| 2024 August | 85 | 56 | 141 |
| 2024 July | 43 | 20 | 63 |
| 2024 June | 70 | 26 | 96 |
| 2024 May | 84 | 34 | 118 |
| 2024 April | 47 | 23 | 70 |
| 2024 March | 50 | 27 | 77 |
| 2024 February | 52 | 36 | 88 |
| 2024 January | 48 | 36 | 84 |
| 2023 December | 58 | 30 | 88 |
| 2023 November | 52 | 33 | 85 |
| 2023 October | 85 | 26 | 111 |
| 2023 September | 81 | 27 | 108 |
| 2023 August | 71 | 26 | 97 |
| 2023 July | 65 | 31 | 96 |
| 2023 June | 76 | 22 | 98 |
| 2023 May | 71 | 28 | 99 |
| 2023 April | 58 | 15 | 73 |
| 2023 March | 78 | 35 | 113 |
| 2023 February | 61 | 18 | 79 |
| 2023 January | 29 | 18 | 47 |
| 2022 December | 45 | 27 | 72 |
| 2022 November | 60 | 31 | 91 |
| 2022 October | 44 | 37 | 81 |
| 2022 September | 32 | 19 | 51 |
| 2022 August | 47 | 37 | 84 |
| 2022 July | 29 | 33 | 62 |
| 2022 June | 44 | 26 | 70 |
| 2022 May | 32 | 32 | 64 |
| 2022 April | 38 | 29 | 67 |
| 2022 March | 38 | 33 | 71 |
| 2022 February | 36 | 40 | 76 |
| 2022 January | 27 | 24 | 51 |
| 2021 December | 35 | 35 | 70 |
| 2021 November | 48 | 34 | 82 |
| 2021 October | 57 | 42 | 99 |
| 2021 September | 25 | 30 | 55 |
| 2021 August | 25 | 36 | 61 |
| 2021 July | 39 | 26 | 65 |
| 2021 June | 26 | 28 | 54 |
| 2021 May | 43 | 17 | 60 |
| 2021 April | 85 | 48 | 133 |
| 2021 March | 30 | 20 | 50 |
| 2021 February | 51 | 23 | 74 |
| 2021 January | 39 | 8 | 47 |
| 2020 December | 28 | 6 | 34 |
| 2020 November | 41 | 7 | 48 |
| 2020 October | 31 | 15 | 46 |
| 2020 September | 29 | 10 | 39 |
| 2020 August | 43 | 13 | 56 |
| 2020 July | 40 | 3 | 43 |
| 2020 June | 38 | 14 | 52 |
| 2020 May | 38 | 12 | 50 |
| 2020 April | 28 | 11 | 39 |
| 2020 March | 32 | 10 | 42 |
| 2020 February | 43 | 16 | 59 |
| 2020 January | 51 | 15 | 66 |
| 2019 December | 51 | 22 | 73 |
| 2019 November | 38 | 17 | 55 |
| 2019 October | 17 | 4 | 21 |
| 2019 September | 41 | 15 | 56 |
| 2019 August | 32 | 18 | 50 |
| 2019 July | 27 | 20 | 47 |
| 2019 June | 36 | 12 | 48 |
| 2019 May | 26 | 10 | 36 |
| 2019 April | 54 | 27 | 81 |
| 2019 March | 21 | 16 | 37 |
| 2019 February | 10 | 10 | 20 |
| 2019 January | 34 | 17 | 51 |
| 2018 December | 42 | 21 | 63 |
| 2018 November | 53 | 11 | 64 |
| 2018 October | 56 | 12 | 68 |
| 2018 September | 43 | 12 | 55 |
| 2018 August | 27 | 10 | 37 |
| 2018 July | 21 | 6 | 27 |
| 2018 June | 17 | 9 | 26 |
| 2018 May | 22 | 10 | 32 |
| 2018 April | 17 | 4 | 21 |
| 2018 March | 24 | 7 | 31 |
| 2018 February | 15 | 2 | 17 |
| 2018 January | 19 | 7 | 26 |
| 2017 December | 25 | 7 | 32 |
| 2017 November | 18 | 4 | 22 |
| 2017 October | 25 | 9 | 34 |
| 2017 September | 26 | 8 | 34 |
| 2017 August | 24 | 5 | 29 |
| 2017 July | 21 | 8 | 29 |
| 2017 June | 25 | 2 | 27 |
| 2017 May | 31 | 8 | 39 |
| 2017 April | 21 | 8 | 29 |
| 2017 March | 17 | 24 | 41 |
| 2017 February | 28 | 5 | 33 |
| 2017 January | 21 | 6 | 27 |
| 2016 December | 46 | 4 | 50 |
| 2016 November | 40 | 7 | 47 |
| 2016 October | 71 | 3 | 74 |
| 2016 September | 84 | 3 | 87 |
| 2016 August | 127 | 2 | 129 |
| 2016 July | 130 | 5 | 135 |
| 2016 June | 97 | 0 | 97 |
| 2016 May | 100 | 0 | 100 |
| 2016 April | 80 | 0 | 80 |
| 2016 March | 59 | 0 | 59 |
| 2016 February | 79 | 0 | 79 |
| 2016 January | 79 | 0 | 79 |
| 2015 December | 90 | 0 | 90 |
| 2015 November | 71 | 0 | 71 |
| 2015 October | 70 | 0 | 70 |
| 2015 September | 51 | 0 | 51 |
| 2015 August | 71 | 0 | 71 |
| 2015 July | 53 | 0 | 53 |
| 2015 June | 30 | 0 | 30 |
| 2015 May | 34 | 0 | 34 |
| 2015 April | 5 | 0 | 5 |
Show all
